首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >PNAS Plus: Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferation
【2h】

PNAS Plus: Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferation

机译:PNAS Plus:糖原合酶激酶(GSK)-3促进p70核糖体蛋白S6激酶(p70S6K)活性和细胞增殖

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The p70 ribosomal protein S6 kinase 1 (S6K1) plays a key role in cell growth and proliferation by regulating insulin sensitivity, metabolism, protein synthesis, and cell cycle. Thus, deregulation of S6K contributes to the progression of type 2 diabetes, obesity, aging, and cancer. Considering the biological and clinical importance of S6K1, a complete understanding of its regulation is critical. One of the key motifs in the activation of S6K1 is a turn motif, but its regulation is not well understood. Here we provide evidence for two mechanisms of modulating turn motif phosphorylation and S6K1 activity. First, mammalian target of rapamycin regulates turn motif phosphorylation by inhibiting its dephosphorylation. Second, we unexpectedly found that glycogen synthase kinase (GSK)-3 promotes turn motif phosphorylation. Our studies show that mammalian target of rapamycin and GSK-3 cooperate to control the activity of S6K1, an important regulator of cell proliferation and growth. Our unexpected results provide a clear rationale for the development and use of drugs targeting GSK-3 to treat diseases such as diabetes, cancer, and age-related diseases that are linked to improper regulation of S6K1.
机译:p70核糖体蛋白S6激酶1(S6K1)通过调节胰岛素敏感性,代谢,蛋白质合成和细胞周期,在细胞生长和增殖中起关键作用。因此,S6K的失调有助于2型糖尿病,肥胖,衰老和癌症的发展。考虑到S6K1的生物学和临床重要性,全面了解其调节至关重要。激活S6K1的关键主题之一是转向主题,但其调控尚不十分清楚。在这里,我们提供了调节转向基序磷酸化和S6K1活性的两种机制的证据。首先,雷帕霉素的哺乳动物靶标通过抑制转磷酸酶的去磷酸化来调节转基因基序的磷酸化。第二,我们出乎意料地发现糖原合酶激酶(GSK)-3促进转弯基序磷酸化。我们的研究表明,雷帕霉素和GSK-3的哺乳动物靶标协同控制S6K1的活性,S6K1是细胞增殖和生长的重要调节剂。我们出乎意料的结果为开发和使用针对GSK-3的药物治疗与S6K1调控不当有关的疾病(如糖尿病,癌症和与年龄有关的疾病)提供了明确的理由。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号